136 related articles for article (PubMed ID: 37818687)
1. Possible association between cerebral white matter atrophy and impaired performance of activities of daily living in patients with Parkinson's disease.
Lu ZH; Chen YK; Fu XL; Chen QT; Yuan SL
Folia Neuropathol; 2023; 61(3):266-272. PubMed ID: 37818687
[TBL] [Abstract][Full Text] [Related]
2. Changes of brain structure in Parkinson's disease patients with mild cognitive impairment analyzed via VBM technology.
Gao Y; Nie K; Huang B; Mei M; Guo M; Xie S; Huang Z; Wang L; Zhao J; Zhang Y; Wang L
Neurosci Lett; 2017 Sep; 658():121-132. PubMed ID: 28823894
[TBL] [Abstract][Full Text] [Related]
3. Structural and functional abnormalities in Parkinson's disease based on voxel-based morphometry and resting-state functional magnetic resonance imaging.
Zheng JH; Sun WH; Ma JJ; Wang ZD; Chang QQ; Dong LR; Shi XX; Li MJ; Gu Q; Chen SY
Neurosci Lett; 2022 Sep; 788():136835. PubMed ID: 35963477
[TBL] [Abstract][Full Text] [Related]
4. Gray matter atrophy associated with mild cognitive impairment in Parkinson's disease.
Chen FX; Kang DZ; Chen FY; Liu Y; Wu G; Li X; Yu LH; Lin YX; Lin ZY
Neurosci Lett; 2016 Mar; 617():160-5. PubMed ID: 26742642
[TBL] [Abstract][Full Text] [Related]
5. [Association of age-related white matter hyperintensity with brain atrophy and cognitive impairment in patients with Parkinson's disease].
Chen HM; Zhang MM; Wang YL
Zhonghua Yi Xue Za Zhi; 2020 Nov; 100(43):3397-3401. PubMed ID: 33238668
[No Abstract] [Full Text] [Related]
6. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
[TBL] [Abstract][Full Text] [Related]
7. Posteroventral medial pallidotomy for treatment of Parkinson's disease: preoperative magnetic resonance imaging features and clinical outcome.
Desaloms JM; Krauss JK; Lai EC; Jankovic J; Grossman RG
J Neurosurg; 1998 Aug; 89(2):194-9. PubMed ID: 9688112
[TBL] [Abstract][Full Text] [Related]
8. Reduced gray matter volume is correlated with frontal cognitive and behavioral impairments in Parkinson's disease.
Terada T; Miyata J; Obi T; Kubota M; Yoshizumi M; Murai T
J Neurol Sci; 2018 Jul; 390():231-238. PubMed ID: 29801896
[TBL] [Abstract][Full Text] [Related]
9. Gray and White Matter Contributions to Cognitive Frontostriatal Deficits in Non-Demented Parkinson's Disease.
Price CC; Tanner J; Nguyen PT; Schwab NA; Mitchell S; Slonena E; Brumback B; Okun MS; Mareci TH; Bowers D
PLoS One; 2016; 11(1):e0147332. PubMed ID: 26784744
[TBL] [Abstract][Full Text] [Related]
10. Loss of integrity and atrophy in cingulate structural covariance networks in Parkinson's disease.
de Schipper LJ; van der Grond J; Marinus J; Henselmans JML; van Hilten JJ
Neuroimage Clin; 2017; 15():587-593. PubMed ID: 28652971
[TBL] [Abstract][Full Text] [Related]
11. Cognitive and motor correlates of grey and white matter pathology in Parkinson's disease.
Dadar M; Gee M; Shuaib A; Duchesne S; Camicioli R
Neuroimage Clin; 2020; 27():102353. PubMed ID: 32745994
[TBL] [Abstract][Full Text] [Related]
12. Influence of diabetes mellitus on longitudinal atrophy and cognition in Parkinson's disease.
Ong M; Foo H; Chander RJ; Wen MC; Au WL; Sitoh YY; Tan L; Kandiah N
J Neurol Sci; 2017 Jun; 377():122-126. PubMed ID: 28477681
[TBL] [Abstract][Full Text] [Related]
13. Basal ganglia atrophy-associated causal structural network degeneration in Parkinson's disease.
Li R; Zou T; Wang X; Wang H; Hu X; Xie F; Meng L; Chen H
Hum Brain Mapp; 2022 Feb; 43(3):1145-1156. PubMed ID: 34792836
[TBL] [Abstract][Full Text] [Related]
14. Severe Lesions Involving Cortical Cholinergic Pathways Predict Poorer Functional Outcome in Acute Ischemic Stroke.
Qu JF; Chen YK; Luo GP; Zhao JH; Zhong HH; Yin HP
Stroke; 2018 Dec; 49(12):2983-2989. PubMed ID: 30571427
[TBL] [Abstract][Full Text] [Related]
15. Hierarchical cluster analysis of multimodal imaging data identifies brain atrophy and cognitive patterns in Parkinson's disease.
Inguanzo A; Sala-Llonch R; Segura B; Erostarbe H; Abos A; Campabadal A; Uribe C; Baggio HC; Compta Y; Marti MJ; Valldeoriola F; Bargallo N; Junque C
Parkinsonism Relat Disord; 2021 Jan; 82():16-23. PubMed ID: 33227683
[TBL] [Abstract][Full Text] [Related]
16. Gray and white matter imaging: A biomarker for cognitive impairment in early Parkinson's disease?
Duncan GW; Firbank MJ; Yarnall AJ; Khoo TK; Brooks DJ; Barker RA; Burn DJ; O'Brien JT
Mov Disord; 2016 Jan; 31(1):103-10. PubMed ID: 26202802
[TBL] [Abstract][Full Text] [Related]
17. Regional gray matter reductions associated with mild cognitive impairment in Parkinson's disease: A meta-analysis of voxel-based morphometry studies.
Zheng D; Chen C; Song W; Yi Z; Zhao P; Zhong J; Dai Z; Shi H; Pan P
Behav Brain Res; 2019 Oct; 371():111973. PubMed ID: 31128163
[TBL] [Abstract][Full Text] [Related]
18. Grey matter atrophy in cognitively impaired Parkinson's disease.
Melzer TR; Watts R; MacAskill MR; Pitcher TL; Livingston L; Keenan RJ; Dalrymple-Alford JC; Anderson TJ
J Neurol Neurosurg Psychiatry; 2012 Feb; 83(2):188-94. PubMed ID: 21890574
[TBL] [Abstract][Full Text] [Related]
19. Cortical atrophy patterns in multiple sclerosis are non-random and clinically relevant.
Steenwijk MD; Geurts JJ; Daams M; Tijms BM; Wink AM; Balk LJ; Tewarie PK; Uitdehaag BM; Barkhof F; Vrenken H; Pouwels PJ
Brain; 2016 Jan; 139(Pt 1):115-26. PubMed ID: 26637488
[TBL] [Abstract][Full Text] [Related]
20. Brain MRI morphometric analysis in Parkinson's disease patients with sleep disturbances.
Radziunas A; Deltuva VP; Tamasauskas A; Gleizniene R; Pranckeviciene A; Petrikonis K; Bunevicius A
BMC Neurol; 2018 Jun; 18(1):88. PubMed ID: 29925331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
